v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows From Operating Activities:    
Net income (loss) $ (4,073,001) $ 2,988,626
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 202,201 206,858
Stock based compensation 879,492 1,307,095
Equity compensation expense 671
Amortization of debt discount 80,205
Non-cash operating lease cost 34,017
Accrued interest on short-term note payable - related party 4,800
Change in fair value of derivative liabilities (884,812) (9,964,250)
Gain on extinguishment of Forward Purchase Agreement (1,297,600)
Changes in operating assets and liabilities:    
Accounts receivable (357) (4,561)
Prepaid expenses 33,208 (57,115)
Other current assets (80,320) (253,887)
Other non-current assets (75,405)
Accounts payable and accrued expenses (319,651) 2,134,207
Income taxes payable (6,369)
Excise taxes 152,247 40,944
Due to related party (12,873)
Operating lease payments (97,583)
Net Cash Used In Operating Activities (5,455,432) (3,607,781)
Cash Flows From Investing Activities:    
Purchases of property and equipment (5,451) (117,812)
Capitalized patent costs (83,229) (96,070)
Net Cash Used In Investing Activities (88,680) (213,882)
Cash Flows From Financing Activities:    
Proceeds from issuance of common stock and warrants in connection with the Private Placement 34,994,842
Offering costs for common stock and warrants issuance in connection with the Private Placement (2,814,747)
Exercise of prefunded warrants 28
Proceeds from issuance of common stock from exercise of warrants 671,568
Proceeds from short-term notes payable 75,000
Proceeds from short-term notes payable – related party 75,000
Repayment of short-term notes payable (696,732) (42,671)
Repurchase of shares (140,000)
Cash used to settle fractional shares (460)
Net Cash Provided By Financing Activities 31,493,391 628,437
Net change in cash 25,949,279 (3,193,226)
Cash at beginning of period 204,725 3,353,732
Cash at end of period 26,154,004 160,506
Supplemental disclosure    
Cash paid for interest expense 35,289 16,627
Cash paid for federal income taxes 6,369
Supplemental disclosure of non-cash financing activities:    
Issuance of stock purchase warrants 1,938,014
Issuance of Common Stock upon cashless exercise of warrants 47
Forward Purchase Agreement discount accretion 236,798
Cancellation of Forward Purchase Agreement 3,078,225
Debt discount recognized on note payable 85,000
Issuance of promissory note in settlement of due to related party 75,000
Convertible notes converted to common shares 527,500
Reclassification of warrant derivative liability to additional paid-in capital upon exercise of Series A warrants 2,024,442
Reverse stock split — reclassification from common stock to additional paid-in capital $ 13,311